- All
- Anesthesiology
- Anti-infectives and immunology
- Biologicals
- Blood disorders
- Cardiovascular
- CNS
- Diabetes
- Endocrinology/Sexual health
- Gastrointestinal Diseases
- General modelling
- Genetic Disorders
- Lung Diseases
- Methods
- Oncology
- Paediatrics
- Pain
- Peripheral Nervous System
- Safety pharmacology
Vendel E., Mohr I., Czlonkowska A., Socha P., Poujois A., Ala A., Sandahl T., Bansal S., Couchonnal E., Praktiknjo M., Leemhuis C., Kruse C., Weiss K.H., Dhawan A., Vis P. Integrated PK-PD model relating serum copper concentrations, urinary copper clearance and trientine pharmacokinetics in Wilson Disease: initial insights from the UNITED study. PAGE, 2025. [Link to publication]
Goulooze S.C., and Snelder N. Causal mediation analysis in a pharmacometrics context. PAGE, 2025. [Link to publication].
Ruppert M., and Noort van M. Performance of Neural Ordinary Differential Equations in a multiple dose pharmacometrics setting. PAGE, 2025. [Link to publication].
DeJongh J., Muliaditan M., Vendel E., Zeiser S, Ruppert M., and Noort van M. A modeller’s perspective on EM methods versus FOCE in NONMEM. PAGE, 2025. [Link to publication]
Xiberras M., Wijk van R.C., Krekels E.H.J., Hasselt van C., Zeilmaker-Roest G., Tibboel D., Wildschut E.D., Knibbe C.A.J., Goulooze S.C. Repeated time to event modelling of morphine pharmacodynamics for analgesia after paediatric cardiac surgery. PAGE, 2025. [Link to publication].
Vendel E., Mohr I., Czlonkowska A., SochaP., Poujois A., Ala A., Sandahl T., Bansal S., Couchonnal E., Praktiknjo M., Leemhuis C., Kruse C., Weiss K.H., Dhawan A., Vis P. Integrated PK-PD model relating serum copper concentrations, urinary copper clearance and trientine pharmacokinetics in Wilson Disease: initial insights from the UNITED study. PAGE 2025 [Link to publication]
Goulooze S.C., Snelder N. Causal mediation analysis in a pharmacometrics context. PAGE 2025 [Link to publication]
Ruppert M., Noort van M. Performance of Neural Ordinary Differential Equations in a multiple dose pharmacometrics setting. PAGE 2025 [Link to publication]
DeJongh J., Muliaditan M., Vendel E., Zeiser S, Ruppert M., Noort van M. A modeller’s perspective on EM methods versus FOCE in NONMEM. PAGE2025 [Link to publication]
Xiberras M., Wijk van R.C., Krekels E.H.J., Hasselt van C., Zeilmaker-Roest G., Tibboel D., Wildschut E.D., Knibbe C.A.J., Goulooze S.C. Repeated time to event modelling of morphine pharmacodynamics for analgesia after paediatric cardiac surgery. PAGE 2025 [Link to publication]
Goulooze S.C, Snelder N. Overadjustment bias and mediation analysis in
PK/PD modeling. Oral presentation at ACoP 2024.
Noort van M., Ruppert M., DeJongh J., Marostica E., Bosch R., Mešic´ E., Snelder N. User-friendly parameter identifiability methods with a workflow to guide model development, using categorical and continuous scales. PAGE 2024 [Link to publication]
Marostica E., Ahsman M., Bragt van T., Noukens J., Vis P., T’joen C., Ulrichts P., Guglietta A., Rossenu S., Steeg van T. Population analysis of MG-ADL total score for efgartigimod Phase 3 study in myasthenia gravis patients: application of a bounded-integer model. PAGE 2024 [Link to publication]
Zeiser S., Rietveld P., Rijcken C., Snelder N. A population PK analysis of docetaxel after IV administration of CPC634 (CriPec® docetaxel) and generic docetaxel in plasma and tumor. PAGE 2024 [Link to publication]
Rietveld P, Koolen S L.W. , Zeiser S., Snelder N., Rijcken C.J. , Koch B.C.P., Mathijssen R.H.J. , Sassen S.D.T. The effect of pH on intratumoural docetaxel release from polymeric nanoparticle CPC634. PAGE 2024 [Link to publication]